| Patent application number | Description | Published |
|---|
| 20080298270 | Upstream Signal Quality Monitoring - The problem is that a measurement of the average signal quality (average modulation error ratio), does not identify poor quality signals that may be originating from an individual cable modem. The device of the present invention displays the modulation error ratio (MER) for each packet received. Since the media access control (MAC) address is associated with a packet received from an individual cable modem, a graph displaying the MER for each packet received is also displaying the MER for signals from the individual cable modems. Thus a technician viewing the display will be able to identify whether a low MER is a result of an impairment in the network or the from an individual cable modem. | 12-04-2008 |
| 20090086804 | Automatic Gain Control Stress Measurement For Digital Carriers - The testing equipment of the present invention calculates a single “AGC stress” value, which provides an indication of the stability of the level of a digital carrier based on the change in gain required to stabilize the power of an incoming cable signal over time. Ideally the AGC stress value is rated on a scale, e.g. 1 to 10 or 0 to 5, and is fed into the DQI measurement system as a new data model. | 04-02-2009 |
| 20090096665 | Method For Locating Cable Impairments - Methods are disclosed for identifying and locating points of impairment in a cable plant, such as that used for cable television (CATV). The methods utilize both known characteristics of signals as well as propagation times in free space and within the cable in conjunction with accurate determination of locations at which measurements are taken. The methods can be applied to both RF cable leaks as well as points of ingress of interference. | 04-16-2009 |
| 20090185037 | MEASURING HUM IN A DIGITAL TV SIGNAL - The invention relates to a method for measuring Hum on a digital QAM carrier using a testing device for testing digital TV signals including a QAM demodulator therein, and to a testing device implementing the method. A micro-controller is used to sample a register associated with an AGC circuit in the QAM demodulator, and to process the collected register values to obtain one or more Hum characteristics. | 07-23-2009 |
| 20090268034 | MEASURING THE FREQUENCY RESPONSE OF A CATV NETWORK - An apparatus and method for frequency sweeping a CATV network, suitable for an upstream path frequency sweeping, is presented. A narrowband test signal is injected into the network by a generator coupled to a cable modem during a time interval allocated by the head end for the cable modem to transmit a modulated digital signal. The amplitude of the test signal is lower than the amplitude of the modulated digital signal, so as not to impair reception of said digital signal at the head end. The frequency of the test signal is swept, and the amplitude of the received test signal is measured. A telemetry or a digital signal transmission is used to communicated the values of the amplitude of the test signals between the injection and the measurement locations of the network. | 10-29-2009 |
| 20100070228 | DETECTING NONLINEARITY IN A CABLE PLANT AND DETERMINING A CABLE LENGTH TO A SOURCE OF THE NONLINEARITY - An apparatus and a method for detecting a nonlinearity in a cable plant and for determining cable length to a source of the nonlinearity are disclosed. Upstream signal peaks are detected by averaging upstream signal waveforms. The upstream signal peaks are generated at the source of the nonlinearity from naturally occurring downstream signal peaks propagating in the cable plant. The downstream signal peaks occur due to constructive superposition of the downstream channel signals. Acquisition of the upstream signal waveforms is triggered by the downstream signal peaks. The cable length to the source of nonlinearity is determined from a time delay between the downstream signal peaks and the upstream signal peaks. | 03-18-2010 |
| 20100309805 | TESTING UPSTREAM CABLE CHANNELS - In order to measure the performance of a DOCSIS upstream channel as well as to locate impairments, a special test signal is transmitted in a time slot of the upstream channel by a test instrument positioned anywhere within the CATV plant. A second test instrument, located at the termination point of the upstream plant, then detects, recovers, and processes the test signal in order to complete the measurement. The typical methods used to detect and recover bursted signals within a DOCSIS upstream channel use precise timing information transmitted in a corresponding DOCSIS downstream channel. Unfortunately, the downstream channel and thus the precise timing information are not always available to the secondary test instrument. The present invention also describes an apparatus and method for detecting a bursted test signal without the use of the DOCSIS upstream channel timing. | 12-09-2010 |
| Patent application number | Description | Published |
|---|
| 20080207701 | OPIOID RECEPTOR ANTAGONISTS - A compound of the formula (I) wherein the variables X | 08-28-2008 |
| 20080255152 | DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS - A compound of the formula (I) wherein the variables X | 10-16-2008 |
| 20080269296 | DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS - A compound of the formula (I) wherein the variables X | 10-30-2008 |
| 20080300289 | Glucagon Receptor Antagonists, Preparation and Therapeutic Uses - The present invention discloses novel compounds of Formula I, or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like. | 12-04-2008 |
| 20080319074 | Glucagon Receptor Antagonists, Preparation and Therapeutic Uses - The present invention discloses novel compounds of Formula (I), or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like. | 12-25-2008 |
| 20100137417 | Glucagon Receptor Antagonists, Preparation and Therapeutic Uses - The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof which have glucagon receptor antagonist or inverse agonist activity, as well as methods of using these compounds and intermediates and methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising N compounds of Formula (I) as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like. | 06-03-2010 |
| 20110105571 | Opioid Receptor Antagonists - A compound of the formula (I) wherein the variables X | 05-05-2011 |
| Patent application number | Description | Published |
|---|
| 20090069648 | INTRA-OCCULAR PRESSURE SENSOR - A system is provided for monitoring intraocular pressure, the system comprising: a sensor package configured to be disposed in the suprachoroidal space of a patient's eye; a pressure sensor; a wireless transceiver disposed within the sensor package and coupled to the pressure sensor; an external transceiver, the external receiver being wirelessly coupled to the wireless transceiver when the transceiver is disposed proximate to the patient's eye. | 03-12-2009 |
| 20100137694 | RADIO TRANSPARENT SENSOR IMPLANT PACKAGE - A system is provided for the packaging of wireless electronics in a mammalian body, the system comprising: a package configured in a shape suitable for implantation in that body; the package being configured from a biocompatible material; and that biocompatible material having a high degree of radio wave transparency. | 06-03-2010 |
| 20100179449 | MINIATURE STENT-BASED IMPLANTABLE WIRELESS MONITORING DEVICES - A system is provided for the transmission of in vivo arterial pressure, the system comprising: an a pressure sensor whereby in vivo arterial pressure data is collected; a wireless transmitter, whereby the in vivo arterial pressure data is transmitted to be received disposed externally to a patient in which the system is disposed; a stent body, the stent body having an integral antenna, and a power source, whereby power is supplied to the system. | 07-15-2010 |
